Mitochondrial Aconitase and Citrate Metabolism in Prostate Tissues
Author Information
Author(s): Keshav K Singh, Mohamed M Desouki, Renty B Franklin, Leslie C Costello
Primary Institution: Roswell Park Cancer Institute
Hypothesis
The study investigates the levels and activity of mitochondrial aconitase in malignant versus nonmalignant prostate tissues.
Conclusion
The study found that the level of mitochondrial aconitase is similar in both malignant and nonmalignant prostate cells, indicating that the limiting factor for citrate oxidation is not the enzyme level but rather the presence of zinc.
Supporting Evidence
- Mitochondrial aconitase was found in both malignant and nonmalignant prostate tissues.
- No significant difference in aconitase levels was observed between benign and malignant glands.
- Zinc levels were found to be down-regulated in malignant glands, affecting citrate oxidation.
Takeaway
This study shows that prostate cancer cells have the same amount of a key enzyme as normal cells, but the cancer cells can use citrate better because they don't have as much zinc blocking the enzyme.
Methodology
The study used immunohistochemical analysis to assess the presence and levels of mitochondrial aconitase in prostate tissue samples.
Limitations
The study did not include sufficient samples of normal glands and prostatic intra-epithelial neoplastic foci for statistical analysis.
Participant Demographics
The study involved 22 cases of prostatic adenocarcinoma, including samples with adjacent benign prostatic hyperplasia and some with normal prostatic glands.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website